Jennifer Joy Rahn

This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 2 EPO patents. Top assignees: Arch Biopartners, Inc., Arch Cancer Therapeutics, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Joy Rahn. Retrieved from https://idiyas.com/inventor/jennifer-joy-rahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 4)

% Patents Active = 75.0

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 63(Granted Patents)

Company Filing History:

4 out of 4

Arch Biopartners, Inc.

patents

4 out of 4

Arch Cancer Therapeutics, Inc.

patents

Years Active: 2013-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12569538 - DPEP-1 Binding Compositions and Methods of Use (2026-03-10),

2. 11666631 - DPEP-1 binding compositions and methods of use (2023-06-06),

3. 11286278 - DPEP-1 binding agents and methods of use (2022-03-29),

4. 11083773 - Peptides that block leukocyte recruitment and methods of use (2021-08-10),

5. 10493127 - DPEP-1 binding compositions and methods of use (2019-12-03),

6. 9464114 - Peptides that block leukocyte recruitment and methods of use (2016-10-11),

7. 9095541 - Brain tumor targeting peptides and methods (2015-08-04),

8. 8530429 - Brain tumor targeting peptides and methods (2013-09-10),

Title: Innovations by Jennifer Joy Rahn

Introduction

Jennifer Joy Rahn is a prominent inventor based in Calgary, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the area of reducing inflammation and treating various medical conditions. With a total of 8 patents to her name, her work has the potential to impact many lives.

Latest Patents

Among her latest patents are the "DPEP-1 binding compositions and methods of use" and "DPEP-1 binding agents and methods of use." These pharmaceutical compositions are designed to reduce inflammation in subjects, block leukocyte recruitment, inhibit tumor metastasis, treat sepsis, and prevent or reduce acute kidney injury. Her innovative approaches in these areas highlight her commitment to advancing medical science.

Career Highlights

Throughout her career, Jennifer has worked with notable companies such as Arch Cancer Therapeutics, Inc. and Arch Biopartners, Inc. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to the advancement of therapeutic solutions.

Collaborations

Jennifer has collaborated with esteemed colleagues, including Stephen Mark Robbins and Donna Lorraine Senger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jennifer Joy Rahn's contributions to the field of pharmaceuticals through her patents and collaborations demonstrate her dedication to improving healthcare solutions. Her work continues to inspire future innovations in medical treatments.

Profile summary based on public USPTO records.